Phibro Animal Health (PAHC) Misses Q3 EPS by 5c; Trims FY16 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Phibro Animal Health Corporation Reports Third Quarter
May 9, 2016 4:17 PM EDTTEANECK, N.J., May 09, 2016 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its third quarter ended March 31, 2016.
Highlights for the March 2016 quarter (compared to the March 2015 quarter, excluding $2 million of prior-year vaccine licensing milestone revenue and income) Net sales of $183 million, a decrease of 1%Adjusted EBITDA of $29.7 million, an increase of 16%Adjusted diluted EPS of $0.38, an increase of 6%Â COMMENTARY
Our third quarter was a continuation of many of the trends we have seen recently, with our... More
